CORESTA Meeting, Smoke Science/Product Technology, 2017, Kitzbühel, ST 62
Overview of in vitro methods used to assess e-cigarettes based on “Toxicity Testing in 21st Century” principles
(1) Imperial Tobacco Ltd, Bristol, U.K.; (2) Fontem Ventures B.V. (an Imperial Brands PLC Company), Amsterdam, The Netherlands
When the National Academies of Sciences released “Toxicity Testing in the 21st Century: A Vision and a Strategy” a new toxicological paradigm was created, focusing on the use of human cell lines and the disruption of key cellular pathways. In keeping with ...